Press Releases

Press Releases

Date	Title	Format
May 4, 2021	Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	PDF Version
April 15, 2021	Chinook Therapeutics Presents Data During the ISN World Congress of Nephrology 2021	PDF Version
April 8, 2021	Chinook Therapeutics to Present at Upcoming Investor Conferences	PDF Version
April 7, 2021	Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results	PDF Version
April 7, 2021	Chinook Therapeutics Announces First Patient Dosed in Phase 2 AFFINITY Basket Study of Atrasentan in Proteinuric Glomerular Diseases	PDF Version
April 5, 2021	Chinook Therapeutics Announces Update on Non-Renal Legacy Programs from Aduro Biotech Merger	PDF Version
April 1, 2021	Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	PDF Version
March 30, 2021	Chinook Therapeutics Announces Upcoming Data Presentations at ISN World Congress of Nephrology 2021 and 58th ERA-EDTA Congress	PDF Version
March 16, 2021	Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 ALIGN Study of Atrasentan for Patients with IgA Nephropathy	PDF Version
March 2, 2021	Chinook Therapeutics to Present at Upcoming Investor Conferences	PDF Version

Email Alerts

Investors